Caveolin and Thrombospondin Expression during Hepatocellular Carcinogenesis

American Journal of Surgical Pathology

Volumn 28, Issue 3, 2004, Pages 357-364

  Yerian, Lisa M ^a   Anders, Robert A ^a   Tretiakova, Maria ^a   Hart, John ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Caveolin; Dysplastic nodule; Liver; Macroregenerative nodule; Thrombospondin

Indexed keywords

CAVEOLIN; THROMBOSPONDIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; DYSPLASIA; DYSPLASTIC LIVER NODULE; ENDOTHELIUM CELL; GENETIC ANALYSIS; HEPATIC ARTERY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER BLOOD FLOW; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER SINUSOID; MACROREGENERATIVE LIVER NODULE; MALIGNANT TRANSFORMATION; NONHUMAN; PORTAL VEIN; PRECANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

CARCINOMA, HEPATOCELLULAR; CAVEOLIN 1; CAVEOLINS; HEPATITIS C; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; PROTEIN ARRAY ANALYSIS; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL;

EID: 1442353835     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200403000-00008     Document Type: Article

References (45)

1. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995;22:983-993.
2. Anders RA, Yerian LM, Tretiakova M, et al. cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am J Pathol. 2003;162:991-1000.
3. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-285.
4. Dhillon AP, Colombari R, Savage K, et al. An immunohistochemical study of the blood vessels within primary hepatocellular tumours. Liver. 1992;12:311-318.
5. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology. 1997;26(suppl):34-38.
6. Feitelson MA, Sun B, Satiroglu Tufan NL. et al. Genetic mechanisms of hepatocarcinogenesis. Oncogene. 2002;21:2593-2604.
7. Fine SW, Lisanti MP, Galbiati F, et al. Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol. 2001;115:719-724.
8. Fra AM, Williamson E, Simons K, et al. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA. 1995;92:8655-8659.
9. Furuya K, Nakamura M, Yamamoto Y, et al. Macroregenerative nodule of the liver: a clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer. 1988;61:99-105.
10. Hayashi K, Kurohiji T, Shirouzu K. Localization of thrombospondin in hepatocellular carcinoma. Hepatology. 1997;25:569-574.
11. Himeno H, Enzan H, Saibara T, et al. Hitherto unrecognized arterioles within hepatocellular carcinoma. J Pathol. 1994;174:217-222.
12. Hui AM, Makuuchi M. Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events. Scand J Gastroenterol. 1999;34:737-742.
13. Ito Y, Yoshida H, Nakano K, et al. Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. Br J Cancer. 2002;86:912-916.
14. Kato K, Hida Y, Miyamoto M, et al. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer. 2002;94:929-933.
15. Kawahara N, Ono M, Taguchi K, et al. Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. Hepatology. 1998;28:1512-1517.
16. Kim SA, Um SJ, Kang JH, et al. Expression of thrombospondin-1 in human hepatocarcinoma cell lines and its regulation by transcription factor Jun/AP-1. Mol Cell Biochem. 2001;216:21-29.
17. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med. 2002;6:1-12.
18. Lee SW, Reimer CL, Oh P, et al. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene. 1998;16:1391-1397.
19. Li S, Couet J, Lisanti MP. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin: caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem. 1996;271:29182-29190.
20. Liu P, Rudick M, Anderson RG. Multiple functions of caveolin-1. J Biol Chem. 2002;277:41295-41298.
21. Mascaux C, Martin B, Paesmans M, et al. Expression of thrombospondin in non-small cell lung cancer. Anticancer Res. 2002;22:1273-1277.
22. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178:493-497.
23. Miyanaga K, Kato Y, Nakamura T, et al. Expression and role of thrombospondin-1 in colorectal cancer. Anticancer Res. 2002;22:3941-3948.
24. Mouraviev V, Li L, Tahir SA, et al. The role of caveolin-1 in androgen insensitive prostate cancer. J Urol. 2002;168:1589-1596.
25. Nakamura S, Muro H, Suzuki S, et al. Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma. Hepatology. 1997;26:407-415.
26. Okamoto M, Ono M, Uchiumi T, et al. Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor beta in human cancer cells: transcriptional activation and messenger RNA stabilization. Biochim Biophys Acta. 2002;1574:24-34.
27. Park YN, Yang CP, Fernandez GJ, et al. Neoangiogenesis and sinusoidal 'capillarization' in dysplastic nodules of the liver. Am J Surg Pathol. 1998;22:656-662.
28. Razani B, Schlegel A, Liu J, et al. Caveolin-1, a putative tumour suppressor gene. Biochem Soc Trans. 2001;29:494-499.
29. Roncalli M, Roz E, Coggi G, et al. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology. 1999;30:1174-1178.
30. Rothberg KG, Heuser JE, Donzell WC, et al. Caveolin, a protein component of caveolae membrane coats. Cell. 1992;68:673-682.
31. Ruck P, Xiao JC, Kaiserling E. Immunoreactivity of sinusoids in hepatocellular carcinoma: an immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Arch Pathol Lab Med. 1995;119:173-178.
32. Sanchez-Carbayo M, Socci ND, Charytonowicz E, et al. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res. 2002;62:6973-6980.
33. Sun M, Eshleman JR, Ferrell LD, et al. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. Hepatology. 2001;33:1415-1424.
34. Suzuoki M, Miyamoto M, Kato K, et al. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer. 2002;87:1140-1144.
35. Terada T, Terasaki S, Nakanuma Y. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy. Cancer. 1993;72:1551-1556.
36. Terada T, Nakanuma Y. Arterial elements and perisinusoidal cells in borderline hepatocellular nodules and small hepatocellular carcinomas. Histopathology. 1995;27:333-339.
37. Terris B, Blaveri E, Cmogorac-Jurcevic T, et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol. 2002;160:1745-1754.
38. Ueda K, Terada T, Nakanuma Y, et al. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol. 1992;23:619-626.
39. Wiechen K, Diatchenko L, Agoulnik A, et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol. 2001;159:1635-1643.
40. Wiechen K, Sers C, Agoulnik A, et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol. 2001;158:833-839.
41. Wikman H, Kettunen E, Seppanen JK, et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene. 2002;21:5804-5813.
42. Wisse E, De Zanger RB, Charels K, et al. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology. 1985;5:683-692.
43. Wong SY, Purdie AT, Han P. Thrombospondin and other possible related matrix proteins in malignant and benign breast disease: an immunohistochemical study. Am J Pathol. 1992;140:1473-1482.
44. Yang G, Truong LD, Timme TL, et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res. 1998;4:1873-1880.
45. Yokomori H, Oda M, Ogi M, et al. Enhanced expression of endothelial nitric oxide synthase and caveolin-1 in human cirrhosis. Liver. 2002;22:150-158.